MeiLan K Han Selected Research

GSK573719

10/2023	Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
1/2023	Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial.
1/2023	A Response to: Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis".
12/2022	Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
12/2022	Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.
1/2022	Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial.
1/2022	Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.
1/2022	Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
6/2021	Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial.
4/2021	InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

MeiLan K Han Research Topics

Disease

163	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 02/2006
27	Emphysema 03/2024 - 01/2014
11	Asthma (Bronchial Asthma) 01/2023 - 07/2012
10	Disease Progression 11/2023 - 12/2009
10	Inflammation (Inflammations) 11/2023 - 01/2017
9	Pneumonia (Pneumonitis) 12/2022 - 03/2012
8	Chronic Bronchitis 11/2023 - 06/2014
5	Dyspnea (Shortness of Breath) 04/2024 - 11/2011
5	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2023 - 09/2015
5	Lung Diseases (Lung Disease) 04/2022 - 01/2016
4	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 03/2012
4	Infections 10/2023 - 02/2006
4	Gastroesophageal Reflux (GERD) 08/2020 - 06/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2020 - 06/2014
3	Anemia 03/2024 - 01/2018
3	Fibrosis (Cirrhosis) 01/2021 - 03/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2019 - 03/2012
3	Idiopathic Pulmonary Fibrosis 01/2017 - 06/2013
2	Obesity 01/2023 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2010
2	COVID-19 05/2022 - 01/2021
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2022
2	Airway Obstruction (Choking) 10/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2021 - 12/2018
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 11/2017 - 01/2016
1	Cough 04/2024
1	Cachexia 11/2023
1	Bronchitis 11/2023
1	Hepatitis C 10/2023
1	Stroke (Strokes) 10/2023
1	Drug Overdose 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 05/2022
1	Headache (Headaches) 05/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2022
1	Dehydration (Water Stress) 01/2022

Drug/Important Bio-Agent (IBA)

45	GoldIBA 05/2024 - 12/2009
33	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2014
21	GSK573719IBA 10/2023 - 05/2018
21	vilanterolIBA 10/2023 - 05/2018
21	fluticasone furoate FDA Link 10/2023 - 05/2018
19	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 06/2010
19	Bronchodilator Agents (Bronchodilators)IBA 01/2024 - 11/2014
10	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 06/2014
9	Oxygen (Dioxygen)IBA 01/2023 - 01/2012
6	CytokinesIBA 05/2022 - 06/2010
6	SmokeIBA 01/2021 - 07/2012
5	Muscarinic AntagonistsIBA 10/2023 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2016
5	C-Reactive ProteinIBA 11/2021 - 08/2015
4	MucinsIBA 11/2023 - 01/2017
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 03/2012
4	Azithromycin (Zithromax)FDA LinkGeneric 12/2021 - 06/2014
3	Hemoglobins (Hemoglobin)IBA 03/2024 - 01/2018
3	Environmental Pollutants (Pollutants, Environmental)IBA 11/2023 - 01/2020
3	Tiotropium Bromide (Spiriva)FDA Link 12/2021 - 02/2016
3	Fibrinogen (Factor I)FDA Link 04/2021 - 01/2019
3	SteroidsIBA 01/2020 - 02/2017
2	Indicators and Reagents (Reagents)IBA 02/2024 - 11/2023
2	CalciumIBA 11/2023 - 01/2017
2	Metoprolol (Toprol-XL)FDA LinkGeneric 11/2023 - 12/2019
2	Surface-Active Agents (Surfactants)IBA 11/2023 - 11/2019
2	OzoneIBA 01/2023 - 01/2017
2	indacaterolIBA 01/2022 - 10/2020
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 01/2022
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 10/2020
2	MacrolidesIBA 12/2021 - 01/2018
2	InterferonsIBA 01/2021 - 01/2021
2	Immunoglobulin E (IgE)IBA 12/2020 - 01/2019
2	Proton Pump InhibitorsIBA 08/2020 - 06/2014
2	Biological FactorsIBA 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2018
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2019 - 08/2016
2	GlucocorticoidsIBA 05/2018 - 06/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 01/2017
2	lipoarabinomannan (LAM)IBA 11/2017 - 01/2016
2	Growth Differentiation Factor 15IBA 01/2017 - 08/2015
2	Interleukin-15 (Interleukin 15)IBA 08/2015 - 06/2010
2	Interleukin-10 (Interleukin 10)IBA 08/2015 - 01/2014
1	IronIBA 03/2024
1	Proline (L-Proline)FDA Link 11/2023
1	Transfer RNA (tRNA)IBA 11/2023
1	Alanine (L-Alanine)FDA Link 11/2023
1	phosphatidylethanolamineIBA 11/2023
1	Aspartic Acid (Aspartate)FDA Link 11/2023
1	Arginine (L-Arginine)FDA Link 11/2023
1	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2023
1	Glutamic Acid (Glutamate)FDA Link 11/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 10/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	AntibodiesIBA 01/2023
1	ruxolitinibIBA 05/2022
1	Janus KinasesIBA 05/2022
1	colistinmethanesulfonic acid (colistimethate sodium)FDA LinkGeneric 01/2022

Therapy/Procedure

48	Therapeutics 11/2023 - 02/2006
18	Nebulizers and Vaporizers (Inhaler) 01/2023 - 05/2018
2	Lung Transplantation 01/2019 - 11/2017